INNOTEST® HCV Ab IV

The fourth dimension in HCV antibody testing.

INNOTEST HCV Ab IV is an enzyme immunoassay for the detection of antibodies to human hepatitis C virus (HCV) in human serum or plasma.

    CE marked
    INNOTEST® HCV Ab IV

    Product number 80068

    192 Tests (2 Plates)
    INNOTEST® HCV Ab IV

    Product number 80330

    480 Tests (5 plates)
    Please contact your local Fujirebio representative for the availability of this product in your country.

    Click here to navigate

    • Details
    • Conditions of sale
    • Citations
    • Documentation
    • Related products
    • Details

      Features & Benefits

      • Cover all the genotypes: Fourth-generation assay using antigens derived from the HCV genotypes 1a, 1b, 2, and 3a
      • High sensitivity in seroconversion panels 
      • Optimal specificity: 99.8% (2005/2009) 
      • Easy integration in your lab: Protocols available for automated processing 
      • Reduced chance of errors and ease-of-use with color-coded reagents

       
      Background

      The INNOTEST HCV Ab IV is an enzyme immunoassay in which the wells of polystyrene microplate strips are coated with a mixture of HCV antigens.

      This 4th generation assay has increased sensitivity due to the use of antigens with improved reactivity, derived from the most prevalent HCV genotypes.

      Antibodies reactive with the core (2 different epitope clusters), NS3, NS4A, NS4B, and NS5A regions of HCV genotypes 1a and 1b, as well as the NS3 and NS4 regions of HCV genotypes 2 and 3a can be detected.

      The assay is easy to use with a sample addition monitoring system, color-coded reagents, and sample volume of 20 µL.

    • Conditions of sale

      To read the end user conditions of sale for this product please visit our Resource center.

    • Citations

      The BIOZ badges associated with Fujirebio products include peer-reviewed citations derived from scientific studies using Fujirebio products. Please note that the peer-reviewed citations do not reflect the regulatory status of Fujirebio products. Users should refer to the specific product documentation and any (clinical) claims made therein in order to ensure compliant use. For each country or geographic region, users must verify the related regulatory status of the Fujirebio product.